Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Monovalent Influenza Vaccine AV024 in Healthy Adults
NCT00240877Phase 3Completed
- Sponsor
- MedImmune
- Start
- Aug 2002
- Primary completion
- Aug 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of AV024 in influenza, sponsored by MedImmune. Started Aug 2002; status: completed.
02
Drugs
AV024
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00240877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240877.